The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis.
Rebecca Haydock, Trish Hepburn, Jonathan Ross, Jane Daniels, Clare Brittain, Louise Jackson, Mara Ozolins, Janet Wilson
Author Information
Rebecca Haydock: Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK. ORCID
Trish Hepburn: Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Jonathan Ross: Department of GU Medicine, University Hospitals Birmingham NHS Foundation Trust, Whittall Street Clinic, Whittall Street, Birmingham, B4 6DH, UK.
Jane Daniels: Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Clare Brittain: Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Louise Jackson: Health Economics Unit, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Mara Ozolins: Nottingham Clinical Trials Unit (NCTU), Applied Health Research Building, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Janet Wilson: GU Medicine Service, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Great George Street, Leeds, LS1 3EX, UK. janet-d.wilson@nhs.net.
